Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence

Table 3 Endoscopic ultrasound ± fine needle aspiration

Ref.	Year	Country	Study design	n	Procedure	Medication	Relative risk
Song et al[18]	2010	South Korea	Prospective	117	EUS + FNA	No medications	No incidence of PPB
Uehara et al[10]	2011	Japan	Retrospective	115	EUS + FNA	No medications	No incidence of PPB
Suzuki et al[11]	2012	United States	Prospective	20	EUS + FNA	No medications	No incidence of PPB
Lee et al[12]	2013	South Korea	Prospective	188	EUS + FNA	No medications	Incidence of PPB 2.1% (25G group). Incidence of PPB 4.3% (22G group)
Vilmann et al[13]	2013	Denmark	Prospective	135	EUS - FNA	No medications	No incidence of PPB
Yang et al[14]	2015	South Korea	Retrospective	76	EUS + FNA	No medications	No incidence of PPB
Mavrogenis et al[15]	2015	United States	Prospective	28	EUS + FNA	No medications	No incidence of PPB
Ramesh et al[19]	2015	South Korea	Prospective	100	EUS + FNA	No medications	No incidence of PPB. Incidence of immediate/intraprocedural bleeding 1.0%
Park et al[16]	2016	Denmark	Prospective	56	EUS + FNA	No medications	No incidence of PPB
Inoue et al[17]	2017	Japan	Retrospective	742	EUS + FNA	No medications	No incidence of PPB
Iwashita et al[20]	2018	South Korea	Prospective	110	EUS + FNA	No medications	No incidence of PPB. Incidence of immediate/intraprocedural bleeding 1.8%

EUS: Endoscopic ultrasound; FNA: Fine needle aspiration; PPB: Post-procedural bleeding.